Changes for page Customer segments in Health and Wellbeing Living Labs
Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 5.11
edited by Sarantis Dimitriadis
on 2022/06/07 10:26
on 2022/06/07 10:26
Change comment:
There is no comment for this version
To version 5.10
edited by Sarantis Dimitriadis
on 2022/06/07 10:20
on 2022/06/07 10:20
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
Details
- Page properties
-
- Content
-
... ... @@ -7,7 +7,7 @@ 7 7 (% class="western" lang="en-GB" style="text-align:justify" %) 8 8 (% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following: 9 9 10 -: 10 +: 11 11 12 12 * ((( 13 13 (% lang="en-US" %)**Non-professional end users:** ... ... @@ -17,7 +17,7 @@ 17 17 * (% lang="en-US" %)**Public health and social service clients: **Those who use public services. 18 18 ))) 19 19 20 -: 20 +: 21 21 22 22 * ((( 23 23 (% lang="en-US" %)**Professional end users** ... ... @@ -29,12 +29,12 @@ 29 29 * (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level. 30 30 ))) 31 31 32 -: 32 +: 33 33 34 34 (% class="western" lang="en-GB" %) 35 35 (% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows: 36 36 37 -: 37 +: 38 38 39 39 * ((( 40 40 (% lang="en-US" %)**Private sector organizations: **(business developers and researchers) ... ... @@ -50,7 +50,7 @@ 50 50 * (% lang="en-US" %)Pharmaceutical companies 51 51 ))) 52 52 53 -: 53 +: 54 54 55 55 * ((( 56 56 (% lang="en-GB" %) ... ... @@ -67,7 +67,7 @@ 67 67 * (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process. 68 68 ))) 69 69 70 -: 70 +: 71 71 72 72 * ((( 73 73 (% lang="en-GB" %) ... ... @@ -82,7 +82,7 @@ 82 82 * (% lang="en-US" %)**Private research organizations** such as technology and innovation centers 83 83 ))) 84 84 85 -: 85 +: 86 86 87 87 * ((( 88 88 (% lang="en-GB" %) ... ... @@ -91,7 +91,7 @@ 91 91 * (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level. 92 92 ))) 93 93 94 -: 94 +: 95 95 96 96 * ((( 97 97 (% lang="en-GB" %) ... ... @@ -104,7 +104,7 @@ 104 104 : 105 105 106 106 (% class="western" lang="en-GB" %) 107 -(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in thefollowing table .107 +(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table . 108 108 109 109 (% style="margin-left:auto; margin-right:auto" %) 110 110 |(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)((( ... ... @@ -333,7 +333,7 @@ 333 333 : 334 334 335 335 (% class="western" lang="en-GB" %) 336 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the tablebelow(% style="page-break-before:always" %).336 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table . 337 337 338 338 |**Researcher expertise**|**Brief use case description** 339 339 |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making